{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"26","upperLimit":"75","value":"61.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"}],"units":"Participants"}],"description":"OS was defined as the time from registration to death of any cause. Participants were followed for a maximum of 3 years from randomization. The median OS with 95% CI was estimated using the Kaplan Meier method","dispersionType":"95% Confidence Interval","groups":[{"description":"Lenalidomide: 25mg once daily orally with food on days 1-21 of 28 day cycle until progression or to a maximum of 18 cycles.\n\nDexamethasone: 10-40 mg once weekly (days 1, 8, 15, \\& 22) orally with food until progression.","id":"OG000","title":"Lenalidomide With On-Demand Dexamethasone"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Time from registration to death (up to 3 years)","title":"Overall Survival (OS)","type":"SECONDARY","unitOfMeasure":"months"}